Publicaciones (78) Publicaciones de Bernardino Miñana López

2024

  1. An Unexpected Seminal Vesicle Pitfall in PSMA PET

    Clinical nuclear medicine, Vol. 49, Núm. 6, pp. e274-e275

  2. First-line Management of Metastatic Urothelial Cancer: Current and Future Perspectives After the EV-302 and CheckMate-901 Studies

    Clinical Genitourinary Cancer

  3. PARP inhibitors alone or in combination for prostate cancer

    Therapeutic Advances in Urology, Vol. 16

2023

  1. Clinical feasibility of combining intraoperative electron radiation therapy with minimally invasive surgery: a potential for electron-FLASH clinical development

    Clinical and Translational Oncology, Vol. 25, Núm. 2, pp. 429-439

  2. Focal Therapy of Prostate Cancer Index Lesion With Irreversible Electroporation. A Prospective Study With a Median Follow-up of 3 Years

    The Journal of urology, Vol. 209, Núm. 1, pp. 261-270

  3. Reply by Authors

    The Journal of urology, Vol. 209, Núm. 1, pp. 270

  4. Revisiting Delphi to Create a Basis for the Future of Focal Therapy for Prostate Cancer

    World Journal of Men's Health

2022

  1. Comparison of surgical approaches to radical prostatectomy in our series beyond oncological and functional outcomes

    Actas Urologicas Espanolas, Vol. 46, Núm. 5, pp. 275-284

2021

  1. Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients

    Cytokine, Vol. 141

  2. Real-world therapeutic management and evolution of patients with benign prostatic hyperplasia in primary care and urology in Spain

    International Journal of Clinical Practice, Vol. 75, Núm. 8

  3. What is the impact of post-radical prostatectomy urinary incontinence on everyday quality of life? Linking Pad usage and International Consultation on Incontinence Questionnaire Short-Form (ICIQ-SF) for a COMBined definition (PICOMB definition)

    Neurourology and Urodynamics, Vol. 40, Núm. 3, pp. 840-847

2020

  1. Health questionnaire analysis and development of satisfaction questionnaire for patients treated with extracorporeal shock wave lithotripsy (SATISLIT)

    Actas Urologicas Espanolas, Vol. 44, Núm. 2, pp. 103-110

  2. Manejo de la hiperplasia benigna de próstata durante la pandemia COVID-19

    Archivos espanoles de urologia, Vol. 73, Núm. 5, pp. 405-412

  3. Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain

    International Journal of Clinical Practice, Vol. 74, Núm. 11

2019

  1. Factors related to early castration resistance in metastatic prostate cancer. Results from the National Prostate Cancer Registry in Spain

    Actas Urologicas Espanolas, Vol. 43, Núm. 10, pp. 562-567

  2. Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer

    International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001

  3. Surgical thromboprophylaxis in daily urologic surgery: Beyond bridge therapy

    Actas Urologicas Espanolas, Vol. 43, Núm. 9, pp. 455-466

2018

  1. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon®) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies

    BJU International, Vol. 122, Núm. 6, pp. 1049-1065

  2. El cáncer de próstata metastásico resistente a la castración en perspectiva 2018

    Archivos Espanoles de Urologia

  3. Factores pronóstico y predictores de respuesta en cáncer de próstata resistente a la castración

    Archivos Espanoles de Urologia, Vol. 71, Núm. 8, pp. 704-710